According to the updated trade data from the General Administration of Customs of China, 2FIRSTS has compiled the e-cigarette export data from China in May 2024.
Data shows that the total e-cigarette exports in May amounted to approximately $1.09 billion, representing a month-on-month increase of 12.8% and a year-on-year increase of 0.1%. This marks the second time since January this year that the figure has surpassed $1 billion.
In May, the United States remained the top destination for e-cigarette exports, reaching $336 million. Following closely behind was the United Kingdom with exports totaling $127 million. South Korea, Russia, and Germany ranked third to fifth respectively, with export amounts of $71.2 million, $69.41 million, and $53 million.
The Netherlands, Malaysia, Canada, the United Arab Emirates, and Poland also ranked in the top ten, with export amounts of $42.23 million, $31.50 million, $23.12 million, $21.77 million, and $17.85 million, respectively.
The total export volume is approximately 23,304 tons, an increase of 13.85% compared to the previous month and an increase of 16.04% compared to the same period last year.
The export unit price is USD 43.31 per kilogram, a decrease of 0.9% month-on-month and 13.7% year-on-year; the average price of "e-cigarettes and similar personal electronic vaporization devices" is USD 4.7 per unit.
Among them, "e-cigarettes and similar personal electronic vaporization devices" account for 22.8% of the export categories, while "products that do not contain tobacco or reconstituted tobacco, but contain nicotine for non-combustible use" account for 77.2%.
Notice
1. This article is provided exclusively for professional research purposes related to industry, technology and policy. Any reference to brands or products is made solely for the purpose of objective description and does not constitute an endorsement, recommendation, or promotion of any brand or product.
2. The use of nicotine products, including but not limited to cigarettes, e-cigarettes, and heated tobacco products, is associated with significant health risks. Users are required to comply with all relevant laws and regulations in their respective jurisdictions.
3. This article is strictly restricted from being accessed or viewed by individuals under the legal age.
Copyright
This article is either an original work by 2Firsts or a reproduction from third-party sources with the original source clearly indicated. The copyright and usage rights of this article belong to 2Firsts or the original source. Unauthorized reproduction, distribution, or any other unauthorized use of this article by any entity or individual is strictly prohibited. Violators will be held legally responsible. For copyright-related matters, please contact: info@2firsts.com
AI Assistance Disclaimer
This article may have utilized AI to enhance translation and editing efficiency. However, due to technical limitations, errors may occur. Readers are advised to refer to the sources provided for more accurate information.
This article should not be used as a basis for any investment decisions or advice, and 2Firsts assumes no direct or indirect liability for any errors in the content.
